Menu Close

ACDM22 Organisation Details


Exhibition Stand: Main Area

Veristat is a scientific-minded CRO with a worldwide presence focused on therapeutic development in North America, Europe, and Asia/Pacific. Veristat supports regulatory strategy, clinical trial design and implementation, data analysis, preparation of marketing applications, and post-marketing pharmacovigilance. We have assembled an extraordinary team of experts who specialize in supporting biopharma in developing the most complex, novel, rare, and advanced therapies. Veristat supported clients in preparing marketing applications for 12% of the 2021 U.S. Food and Drug Administration (FDA) novel drug approvals.

Biometrics Expertise for Clinical Trials and Regulatory Submissions

Advancing a novel therapy through clinical development is complicated.   Not all therapies make it to the patients that need them, not because they did not work, but because the design, data collection and/or analysis were not done right. Correctly designing, collecting, analyzing, standardizing, and reporting your clinical trial data to local and global regulatory agencies is critical to your success. To give you an advantage, Veristat has assembled an extraordinary team of scientific-minded biostatisticians, programmers, data managers and data standards experts, the power of industry-leading technology platforms and expertise in adaptive designs, to help you understand your data to make critical clinical development decisions.